Examiner: ABBOTT, KODYE LEE

Tech Center 1600 • Art Units: 1634

This examiner grants 53% of resolved cases

Analysis

Kodye Lee Abbott is an examiner in Tech Center 1600 and Art Unit 1634. Across 32 resolved cases, the allowance rate is 53.1 percent. This indicates a moderate level of difficulty, where roughly half of the applications are successfully granted.

The most striking data point is the interview lift of 71.4 percent. This is an exceptionally high figure, suggesting that interviews are the single most effective tool for overcoming rejections with this examiner. The 71.4 percent lift implies that verbal communication is far more successful than written advocacy alone.

The median days to allowance is 1294. While the 53.1 percent allowance rate is average, the 1294-day timeline is substantial. Practitioners should prioritize interviews to leverage the 71.4 percent lift and navigate the lengthy prosecution period more effectively.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

53.1%

Allow Rate

-6.9% vs TC avg

Total Applications

+71.4%

Interview Lift

1294

Avg Prosecution Days

Based on 32 resolved cases, 2023–2026

Rejection Statute Breakdown

3.9%

§101 Eligibility

18.3%

§102 Novelty

40.4%

§103 Obviousness

33.0%

§112 Clarity

Currently Pending Office Actions

App #	Title	Status	Assignee
18625271	HIGH THROUGHPUT LOCALIZED PASSIVE DIFFUSION DEVICE FOR PATTERNING ORGANOIDS	Non-Final OA	University of Massachusetts
17634720	IMMUNORESPONSIVE CELLS ARMOURED WITH SPATIOTEMPORALLY RESTRICTED ACTIVITY OF CYTOKINES OF THE IL-1 SUPERFAMILY	Final Rejection	King's College London
17921174	ISOLATION AND FUNCTIONAL ANALYSIS OF EPITHELIAL PROGENITOR CELLS FROM THE HUMAN LUNG	Final Rejection	CEDARS-SINAI MEDICAL CENTER
17910686	GENE THERAPY OF NIEMANN-PICK DISEASE TYPE C	Non-Final OA	UCL BUSINESS LTD
18255444	RETROVIRAL VECTORS	Final Rejection	UCL Business LTD
17773467	METHOD FOR PRODUCING T CELLS	Non-Final OA	Takeda Pharmaceutical Company Limited
17605639	GENE KNOCK-OUTS TO IMPROVE T CELL FUNCTION	Final Rejection	ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
18257802	HEK293T CELL STRAIN HAVING HIGH DISPERSIBILITY AND SCREENING METHOD THEREFOR	Non-Final OA	ZHENJIANG PROBIO BIOTECH CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy